Targeted Delivery of alpha-Galactosylceramide to CD8 alpha(+) Dendritic Cells Optimizes Type I NKT Cell-Based Antitumor Responses

Author(s):
Macho-Fernandez, E.; Cruz, L.J.; Ghinnagow, R.; Fontaine, J.; Bialecki, E.; Frisch, B.; Trottein, F.; Faveeuw, C.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-07-15
Language
English
Is part of
Journal of Immunology (2014), Vol. 193, no. 2, p. 961-969
hdl
1887/107112
doi
10.4049/jimmunol.1303029